Avoid common mistakes on your manuscript.
Presentation
A 6-year-old boy with juvenile dermatomyositis (JDM) positive for anti-TIF1y antibodies for 3 years on methotrexate (1 mg/kg) reported with recurrent heliotrope and Gottron’s rashes, and muscle weakness refractory to corticosteroids (1 mg/kg) for 3 months. He progressively developed periorbital edema, oral ulcers, and skin ulcers over the trunk. On examination, Gottron’s papules, periungual desquamation, ulcerative rash on the anterior of the middle finger, ulcerative rash over the back and umbilicus, periorbital edema with partly healed heliotrope rash, and gingival vasculopathy (Fig. 1) were noted. The gingival changes may be surrogate for an underlying vasculitis which signifies severe JDM, also supported by the poor response to high-dose corticosteroids. Therefore, the child was treated with intravenous methylprednisolone and rituximab. Over the next 5 months, the child gradually improved with complete resolution of the heliotrope rash, gingival vasculopathy, skin ulcers, and periungual rash.
Discussion
The periungual rash in this case signifies capillary changes which have been reported frequently in patients with JDM, although the similar phenomenon of capillary dilatation, erythema, and bush-loop formation affecting the mucosal capillaries in the form of gingival vasculopathy is uncommonly recognized [1]. Oral telangiectasia have been described in both adults and children, albeit more commonly in the latter [1]. The gingival edema and hypertrophy have been described as an epiphenomenon to the capillary changes rather than a primary feature of JDM. Vasculitis forms an integral component of the Disease Activity Index score for JDM inclusive of the eyelid and periungual capillary changes along with palatal vessel dilatation [2]. Furthermore, the oral changes may mark a widespread capillary involvement in the gastrointestinal tract and intravenous steroids may be preferred for induction in these patients [3]. Gingival vasculopathy is associated with cutaneous activity with refractory disease and thus represents a possible site for assessment of disease activity and response in JDM akin to nail fold capillaroscopy [4, 5].
References
Savioli C, Silva CAA, Fabri GMC, Kozu K, Campos LMA, Bonfa E, Sallum AME, de Siqueira JTT (2010) Gingival capillary changes and oral motor weakness in juvenile dermatomyositis. Rheumatology 49:1962–1970. https://doi.org/10.1093/rheumatology/keq189
Bode RK, Klein-Gitelman MS, Miller ML, Lechman TS, Pachman LM (2003) Disease activity score for children with juvenile dermatomyositis: reliability and validity evidence. Arthritis Care Res 49:7–15. https://doi.org/10.1002/art.10924
Rouster-Stevens KA, Gursahaney A, Ngai K-L, Daru JA, Pachman LM (2008) Pharmacokinetic study of oral prednisolone compared with intravenous methylprednisolone in patients with juvenile dermatomyositis. Arthritis Rheum 59:222–226. https://doi.org/10.1002/art.23341
Ghali FE, Stein LD, Fine JD, Burkes EJ, McCauliffe DP (1999) Gingival telangiectases: an underappreciated physical sign of juvenile dermatomyositis. Arch Dermatol 135:1370–1374. https://doi.org/10.1001/archderm.135.11.1370
Rider LG, Atkinson JC (2009) Images in clinical medicine. Gingival and periungual vasculopathy of juvenile dermatomyositis. N Engl J Med 360:e21. https://doi.org/10.1056/NEJMicm062850
Author information
Authors and Affiliations
Contributions
All authors were involved in manuscript ideation and preparation.
Corresponding author
Ethics declarations
Consent to participate
The father has provided a signed consent to submit this article to be published. He has seen the image, text, and other materials.
Disclosures
None.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Khan, H., Mehta, P. & Gupta, L. Juvenile dermatomyositis with gingival vasculopathy. Clin Rheumatol 40, 3369–3370 (2021). https://doi.org/10.1007/s10067-021-05666-y
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-021-05666-y